Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBF beta/MYH11-positive acute myeloblastic leukemia

Blood. 1997 Mar 15;89(6):2222-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Polymerase Chain Reaction*
  • Predictive Value of Tests
  • Prognosis

Substances

  • CBFbeta-MYH11 fusion protein
  • Oncogene Proteins, Fusion